SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
CHARLES RIVER
(NYSE:CRL Last Sale: 138.35 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NYSE: (CRL : $138.35)
$6,846,217 million Market Cap at Market Close, July 1, 2022
Employs 8,400.
Biomedics SubIndustry up .00% / Health Industry up .00% Today
251 Ballardvale Street Research Report Earnings Snapshot - Last 10/29/18
Wilmington, MA 01887 Fact Sheet
Phone: (978) 658-6000 Financial Statements
Fax: (978) 658-7132 Peer Comparison
Annual Reports

James C. Foster, Chmn./Pres./CEO, Thomas F. Ackerman, CFO
Provides research tools and support services that enable drug discovery and development. IPO at $16 June 22, 2000. Raised $200 million, selling 12.5 million shares, 39% of the outstanding. Lead Manager: Donaldson, Lufkin and Jenrette. Acquired INVERESK RESEARCH GROUP INC (Nasdaq:IRGI) October 20, 2004 for 17.3 million shares, issuing 0.48 CRL per IRGI. Cancelled $1.6 billion purchase of Chinese research firm WuXi PharmaTech July 30, 2010, and announced stock buy back.
Historical Charts    Technical Analysis
No Historical Data available for CRL

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common CRL $138.35 $138.35 0 .0 $136 $139.12 275,063 $136 $139.12 49,484,761
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock #############

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex